DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pdzg52/the_market_for_in) has announced the addition of the "The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)" report to their offering.
This comprehensive report identifies the key topics within the Latin America In Vitro Diagnostic Tests market that all market participants should be aware of. It considers current and future drivers, challenges and opportunities, providing the confidence needed to make informed business decisions.
Kalorama Information's exclusive market estimates provides knowledge of the total manufacturer earnings in a given market within each major country. The segments under analysis include reagents, consumables, calibrators and controls of the following sub-segments: Basic Chemistries and Blood Gas, Hematology, Immunology, Infectious Disease Immunochemistry, Coagulation, Bloodbanking, Urine Testing, Infectious Disease, Molecular Infectious Disease, Nucleic Acid Testing, Cytometry, Primary Staining Histology, Advanced Staining Histology, Cardiovascular Biomarkers.
Kalorama Information is a healthcare market research publisher and reports in healthcare and specializes in IVD as well as biotechnology and devices. Kalorama is the publisher of the Worldwide Market for In Vitro Diagnostics, 9th Edition. In this effort, Kalorama has joined with VA Consultora, a recognized market research and laboratory survey company in Buenos Aires, Argentina.
Companies profiled in the report include:
- Roche Diagnostics
- Siemens Healthcare
- Labin Peru
- WM Argentina
- Andina Medica
- Becton Dickinson
- Belomed SRL
- Wiener Lab/Labinbraz
- Jampar Multiplest Internacional
- Johnson & Johnson
ONE: EXECUTIVE SUMMARY
SEVEN: URUGUAY, VENEZUELA, ECUADOR AND THE REST OF LATIN AMERICA
EIGHT: COMPANY PROFILES
For more information visit http://www.researchandmarkets.com/research/pdzg52/the_market_for_in